Investor Overview

Webcast ImageWebcast
Elan Corporation Corporate Update Conference Call May 20, 2013 (Replay)
05/20/13 at 8:30 a.m. ET
Elan Corporation Corporate Update Conference Call May 20, 2013
Monday, May 20, 2013 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Company Overview:

 

Elan Corporation, plc is a biotechnology company, headquartered in Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan was incorporated as a private limited company in Ireland in December 1969 and became a public limited company in January 1984. Elan shares trade on the New York and Irish Stock Exchanges.

What's New:

 
2012 Annual Report

Stock Quote:

 
ELN (ADS Common)
PriceChange% ChangeVolume
$12.04 - 0.030.25%12,912,030
Previous CloseToday's OpenIntraday HighIntraday Low
$12.07$12.07$12.11$12.02
05/22/13 4:04 p.m. ET
Minimum 20 minute delay

Recent Financial News:

More >>

 
20 May 2013
Elan Announces Transactions: Decisively Transforming the Company
Proposed Transactions offer shareholders highly unique investment and asset proposition Acquisition of AOP Orphan – a private, orphan disease company headquartered in Vienna, Austria Acquires 48% of Newbridge Pharmaceuticals – a private Africa, Middle East & Turkey (AfMET) company, headquartered in Dubai, UAE AOP & Newbridge together reach 20%+ of the world’s growing population ... 
20 May 2013
Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021
DUBLIN--(BUSINESS WIRE)--May. 20, 2013-- Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced that its wholly-owned subsidiaries, Elan Finance public limited company (“Elan Finance”) and Elan Finance Corp. (“Elan Corp.” and together with Elan Finance, the “Issuers”), intend to offer, subject to market conditions, US$800.0 million in aggregate principal amount of Senior Notes due 2021 (the “Notes”). The Notes will be fully and unconditionally guaran... 
20 May 2013
Elan's Response to Royalty Pharma Announcement
DUBLIN--(BUSINESS WIRE)--May. 20, 2013-- The Board of Elan Corporation, plc (NYSE : ELN) (Elan) notes today’s announcement regarding the revised offer by Echo Pharma Acquisition Limited (“Royalty Pharma”) to acquire Elan's shares under Rule 2.5 of the Irish Takeover Rules. The Board of Elan will, as before, in line with its obligations under Irish Takeover law, assess the Royalty Pharma announcement and will advise its shareholders accordi... 
15 May 2013
Elan Announces Publication of Response Document
DUBLIN--(BUSINESS WIRE)--May. 15, 2013-- Elan Corporation, plc (NYSE : ELN) (Elan) today announces publication of a response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) offer made on May 2, 2013. The response document is published in accordance with Rules 25 and 30.3 of the Irish Takeover Rules and the United States tender offer rules. As previously advised, the Board of Elan has unanimously, and without res... 

Upcoming Events:

More >>

 
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Elan Corporation, PLC posts new information to the site. Just enter your e-mail address and click Submit.
 
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Contact IR